Anti-VEGF: A new therapeutic option in hereditary hemorrhagic telangiectasia

被引：2

作者：

Dupuis-Girod, Sophie ^{[1
,2
]}

机构：

[1] Hosp Civils Lyon, Hop Louis Pradel, Serv Genet, F-69677 Bron, France

[2] Ctr Reference Malad Rendu Osler, F-69677 Bron, France

来源：

PRESSE MEDICALE | 2013年 / 42卷 / 04期

关键词：

LIVER-TRANSPLANTATION; BEVACIZUMAB; INVOLVEMENT;

D O I：

10.1016/j.lpm.2012.11.009

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：385 / 387

页数：3

共 11 条

[1] Liver involvement in hereditary hemorrhagic telangiectasia:: consensus recommendations [J].

Buscarini, Elisabetta ;

Plauchu, Henry ;

Tsao, Guadalupe Garcia ;

White, Robert I., Jr. ;

Sabba, Carlo ;

Miller, Franklin ;

Saurin, Jean Cristophe ;

Pelage, Jean Pierre ;

Lesca, Gaetan ;

Marion, Marie Jeanne ;

Perna, Annalisa ;

Faughnan, Marie E. .

LIVER INTERNATIONAL, 2006, 26 (09) :1040-1046

[2] Hereditary hemorrhagic telangiectasia: from molecular biology to patient care [J].

Dupuis-Girod, S. ;

Bailly, S. ;

Plauchu, H. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (07) :1447-1456

[3] Bevacizumab in Patients With Hereditary Hemorrhagic Telangiectasia and Severe Hepatic Vascular Malformations and High Cardiac Output [J].

Dupuis-Girod, Sophie ;

Ginon, Isabelle ;

Saurin, Jean-Christophe ;

Marion, Denis ;

Guillot, Elsa ;

Decullier, Evelyne ;

Roux, Adeline ;

Carette, Marie-France ;

Gilbert-Dussardier, Brigitte ;

Hatron, Pierre-Yves ;

Lacombe, Pascal ;

Lorcerie, Bernard ;

Riviere, Sophie ;

Corre, Romain ;

Giraud, Sophie ;

Bailly, Sabine ;

Paintaud, Gilles ;

Ternant, David ;

Valette, Pierre-Jean ;

Plauchu, Henri ;

Faure, Frederic .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (09) :948-955

[4] Long-Term Outcome of Patients with Hereditary Hemorrhagic Telangiectasia and Severe Hepatic Involvement After Orthotopic Liver Transplantation: a single-Center study [J].

Dupuis-Girod, Sophie ;

Chesnais, Anne-Laure ;

Ginon, Isabelle ;

Dumortier, Jerome ;

Saurin, Jean-Christophe ;

Finet, Gerard ;

Decullier, Evelyne ;

Marion, Denis ;

Plauchu, Henri ;

Boillot, Olivier .

LIVER TRANSPLANTATION, 2010, 16 (03) :340-347

[5] Evaluation of Previously Nonscreened Hereditary Hemorrhagic Telangiectasia Patients Shows Frequent Liver Involvement and Early Cardiac Consequences [J].

Gincul, Rodica ;

Lesca, Gaetan ;

Gelas-Dore, Benedicte ;

Rollin, Nathalie ;

Barthelet, Martine ;

Dupuis-Girod, Sophie ;

Pilleul, Franck ;

Giraud, Sophie ;

Plauchu, Henri ;

Saurin, Jean-Christophe .

HEPATOLOGY, 2008, 48 (05) :1570-1576

[6]

Ginon I, 2013, EUR J INTERN MED

[7] Worsening of Nose Bleeding Heralds High Cardiac Output State in Hereditary Hemorrhagic Telangiectasia [J].

Khalid, Sakib K. ;

Pershbacher, James ;

Makan, Majesh ;

Barzilai, Benico ;

Goodenberger, Daniel .

AMERICAN JOURNAL OF MEDICINE, 2009, 122 (08) :779.e1-779.e9

[8] Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia [J].

Mitchell, Andrew ;

Adams, Leon A. ;

Mac Uillan, Gerry ;

Tibballs, Jon ;

Driesen, Rohan Vanden ;

Delriviere, Luc .

LIVER TRANSPLANTATION, 2008, 14 (02) :210-213

[9]

Shovlin CL, 2000, AM J MED GENET, V91, P66, DOI 10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO

[10]

2-P

← 1 2 →